Activist investor Carl Icahn buys Citigroup Inc., Endo Pharmaceuticals Holdings Inc., Advanced Micro Devices Inc., Exelixis Inc., TakeTwo Interactive Software Inc., sells Applera Corp. Applied Biosystems Group, WCI Communities Inc. during the 3-months ended 09/30/2008, according to the most recent filings of his investment company, Icahn Capital Management LP. Carl Icahn owns 29 stocks with a total value of $4.5 billion. These are the details of the buys and sells.
New Purchases: AMD, C, ENDP, EXEL, TTWO,
Added Positions: AMLN, APC, BIIB, QRCP, WMB,
Reduced Positions: TWC,
Sold Out: ABI,
For the details of Carl Icahn's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Carl+Icahn
Added: Biogen Idec Inc (BIIB, Financial)
Carl Icahn added to his holdings in Biogen Idec Inc by 40.81%. His purchase prices were between $48.59 and $69.5, with an estimated average price of $54.6. The impact to his portfolio due to this purchase was 4.56%. His holdings were 14,009,043 shares as of 09/30/2008.
IDEC Pharmaceuticals Corporation is a biopharmaceutical company engaged primarily in the research development and commercialization of targeted therapies for the treatment of cancer and autoimmune and inflammatory diseases. Their first commercial product Rituxan and our most advanced product candidate ZEVALIN are for use in the treatment of certain B-cellnon-Hodgkin's lymphomas. They are also developing products for the treatment of various autoimmune diseases (such as psoriasis rheumatoidarthritis and lupus). Biogen Idec Inc has a market cap of $12.58 billion; its shares were traded at around $43.13 with a P/E ratio of 16.49 and P/S ratio of 3.21.
Added: Anadarko Petroleum Corp. (APC, Financial)
Carl Icahn added to his holdings in Anadarko Petroleum Corp. by 11.68%. His purchase prices were between $52.73 and $70.47, with an estimated average price of $59.8. The impact to his portfolio due to this purchase was 1.82%. His holdings were 16,084,356 shares as of 09/30/2008.
Anadarko Petroleum Corporation is one of the world's largest independentoil and gas exploration and production companies. Majority of the company'stotal proved reserves are located in the U.S. primarily in the mid-continent (Kansas Oklahoma and Texas) area offshore in the Gulf of Mexico and in Alaska. Most of the company's production is domestic and the remainder is from Algeria. The company also owns and operates gas gathering systems in its U.S. core producing areas. Anadarko Petroleum Corp. has a market cap of $17.3 billion; its shares were traded at around $37.68 with a P/E ratio of 6.47 and P/S ratio of 1.19. The dividend yield of Anadarko Petroleum Corp. stocks is 0.99%.
Added: Amylin Pharmaceuticals Inc. (AMLN, Financial)
Carl Icahn added to his holdings in Amylin Pharmaceuticals Inc. by 57.91%. His purchase prices were between $20.18 and $34.21, with an estimated average price of $25.8. The impact to his portfolio due to this purchase was 1.78%. His holdings were 10,718,586 shares as of 09/30/2008.
Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery development and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes SYMLIN injection and BYETTA injection. Amylin's research and development activities leverage the company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is located in San Diego California with over one thousand five hundred employees nationwide. Amylin Pharmaceuticals Inc. has a market cap of $950.93 million; its shares were traded at around $6.91 with P/S ratio of 1.11.
Added: The Williams Companies Inc. (WMB, Financial)
Carl Icahn added to his holdings in The Williams Companies Inc. by 84.32%. His purchase prices were between $25.49 and $37.66, with an estimated average price of $30.5. The impact to his portfolio due to this purchase was 1.75%. His holdings were 7,223,264 shares as of 09/30/2008.
Williams Companies moves manages and markets a variety of energy products including natural gas liquid hydrocarbons petroleum and electricity. Based in Tulsa Oklahoma Williams' operations span the energy value chain from wellhead to burner tip. The Williams Companies Inc. has a market cap of $9.65 billion; its shares were traded at around $16.69 with a P/E ratio of 6.51 and P/S ratio of 0.76. The dividend yield of The Williams Companies Inc. stocks is 2.26%.
Added: Quest Resource Corp. (QRCP, Financial)
Carl Icahn added to his holdings in Quest Resource Corp. by 41.47%. His purchase prices were between $2.6 and $10.26, with an estimated average price of $6.8. The impact to his portfolio due to this purchase was 0.02%. His holdings were 1,228,002 shares as of 09/30/2008.
Quest Resource Corp. has a market cap of $9.59 million; its shares were traded at around $0.4 with P/S ratio of 0.06.
New Purchase: Citigroup Inc. (C, Financial)
Carl Icahn initiated holdings in Citigroup Inc.. His purchase prices were between $15.72 and $20.39, with an estimated average price of $18.4. The impact to his portfolio due to this purchase was 0.37%. His holdings were 800,000 shares as of 09/30/2008.
Citigroup Inc. the leading global financial services company has some two hundred million customer accounts and does business in more than hundred countries providing consumers corporations governments and institutions with a broad range of financial products and services including consumer banking and credit corporate and investment banking securities brokerage and wealth management. Major brand names under Citigroup's trademark red umbrella include Citibank CitiFinancial Primerica Smith Barney and Banamex. Citigroup Inc. has a market cap of $48.45 billion; its shares were traded at around $8.89 with P/S ratio of 1.77. The dividend yield of Citigroup Inc. stocks is 5.41%.
New Purchase: Endo Pharmaceuticals Holdings Inc. (ENDP, Financial)
Carl Icahn initiated holdings in Endo Pharmaceuticals Holdings Inc.. His purchase prices were between $20.58 and $25.19, with an estimated average price of $23.1. The impact to his portfolio due to this purchase was 0.36%. His holdings were 800,000 shares as of 09/30/2008.
Endo Pharmaceuticals Holdings Inc. through its wholly owned subsidiaries Endo Pharmaceuticals Inc. and Endo Inc. is engaged in the research development sales and marketing of branded and generic prescription pharmaceuticals used primarily for the treatment and management of pain. Endo Pharmaceuticals Holdings Inc. has a market cap of $2.34 billion; its shares were traded at around $19.97 with a P/E ratio of 10.78 and P/S ratio of 1.92.
New Purchase: Advanced Micro Devices Inc. (AMD, Financial)
Carl Icahn initiated holdings in Advanced Micro Devices Inc.. His purchase prices were between $4.28 and $6.29, with an estimated average price of $5.3. The impact to his portfolio due to this purchase was 0.19%. His holdings were 1,600,000 shares as of 09/30/2008.
Advanced Micro Devices Inc. is a world-class company with the innovation execution and vision to grow our leadership position in the industry. Today's world-class companies share three essential characteristics. First they deliver innovative products and technologies that customers want. Second they have established a proven track record of fast efficient manufacturing execution. And third they have a bold vision of where to take their business and often their industry. Over the course of AMD?s three decades in business silicon and software have become the steel and plastic of the worldwide digital economy. Technology companies have become global pacesetters making technical advances at a prodigious rate always driving the industry to deliver more and more faster and faster. AMD?s dedication to customer-centric innovation and competitive spirit is an unbroken thread running from our early days in the integrated circuit business through an ever-broadening product por Advanced Micro Devices Inc. has a market cap of $1.52 billion; its shares were traded at around $2.5 with P/S ratio of 0.23.
New Purchase: Exelixis Inc. (EXEL, Financial)
Carl Icahn initiated holdings in Exelixis Inc.. His purchase prices were between $4.8 and $7.12, with an estimated average price of $6.1. The impact to his portfolio due to this purchase was 0.18%. His holdings were 1,307,280 shares as of 09/30/2008.
Exelixis Inc. is a leader in the fields of model system genetics andcomparative genomics. These fields involve the systematic study of simpleorganisms such as fruit flies nematodes mice zebrafish and simple plants to rapidly and efficiently determine gene function and establish its commercial utility in humans and other commercially important biological systems. The proprietary technologies provide a rapid efficient and cost-effective way to move beyond DNA sequence data to understand the function of genes and the proteins that they encode. Exelixis Inc. has a market cap of $316.80 million; its shares were traded at around $3 with P/S ratio of 2.70.
New Purchase: TakeTwo Interactive Software Inc. (TTWO, Financial)
Carl Icahn initiated holdings in TakeTwo Interactive Software Inc.. His purchase prices were between $16.16 and $25.07, with an estimated average price of $22.9. The impact to his portfolio due to this purchase was 0.17%. His holdings were 461,128 shares as of 09/30/2008.
Take-Two Interactive Software Inc. is a leading worldwide developer publisher and distributor of interactive software games. The company's software operates on multimedia personal computers and video game console platforms. They are one of the largest distributors of interactive software games in the United States and one of the top publishers of interactive software games in Europe. TakeTwo Interactive Software Inc. has a market cap of $798.35 million; its shares were traded at around $10.29 with a P/E ratio of 7.33 and P/S ratio of 0.53.
Reduced: Time Warner Cable Inc. (TWC, Financial)
Carl Icahn reduced to his holdings in Time Warner Cable Inc. by 32.25%. His sale prices were between $25.24 and $28.85, with an estimated average price of $26.9. The impact to his portfolio due to this sale was -0.22%. Carl Icahn still held 1,248,474 shares as of 09/30/2008.
Time Warner Cable Inc. is the second-largest cable operator in the U.S. and an industry leader in developing and launching innovative video data and voice services. They deliver their services to customers over technologically-advanced well-clustered cable systems that pass approximately 26 million homes. Time Warner Cable Inc. has a market cap of $18.92 billion; its shares were traded at around $19.37 with a P/E ratio of 16.51 and P/S ratio of 1.12.
Sold Out: Applera Corp. Applied Biosystems Group (ABI)
Carl Icahn sold out his holdings in Applera Corp. Applied Biosystems Group. His sale prices were between $32.99 and $36.56, with an estimated average price of $35.4. The impact to his portfolio due to this sale was less than 0.01%.
APPLIED BIOSYSTEMS INC. (formerly known as Applera Corporation) is a global leader in the development and marketing of instrument-based systems consumables software and services for academic research the life science industry and commercial markets. Driven by its employees' belief in the power of science to improve the human condition the company commercializes innovative technology solutions for DNA RNA protein and small molecule analysis. Customers across the disciplines of academic and clinical research pharmaceutical research and manufacturing forensic DNA analysis and agricultural biotechnology use the company?s tools and services to accelerate scientific discovery improve processes related to drug discovery and development detect potentially pathogenic microorganisms and identify individuals based on DNA sources. Applied Biosystems has a comprehensive service and field applications support team for a global installed base of high-performance genetic and prote Applera Corp. Applied Biosystems Group has a market cap of $4.95 billion; its shares were traded at around $29.05 with a P/E ratio of 15.27 and P/S ratio of 2.19. The dividend yield of Applera Corp. Applied Biosystems Group stocks is 0.56%.
New Purchases: AMD, C, ENDP, EXEL, TTWO,
Added Positions: AMLN, APC, BIIB, QRCP, WMB,
Reduced Positions: TWC,
Sold Out: ABI,
For the details of Carl Icahn's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Carl+Icahn
Added: Biogen Idec Inc (BIIB, Financial)
Carl Icahn added to his holdings in Biogen Idec Inc by 40.81%. His purchase prices were between $48.59 and $69.5, with an estimated average price of $54.6. The impact to his portfolio due to this purchase was 4.56%. His holdings were 14,009,043 shares as of 09/30/2008.
IDEC Pharmaceuticals Corporation is a biopharmaceutical company engaged primarily in the research development and commercialization of targeted therapies for the treatment of cancer and autoimmune and inflammatory diseases. Their first commercial product Rituxan and our most advanced product candidate ZEVALIN are for use in the treatment of certain B-cellnon-Hodgkin's lymphomas. They are also developing products for the treatment of various autoimmune diseases (such as psoriasis rheumatoidarthritis and lupus). Biogen Idec Inc has a market cap of $12.58 billion; its shares were traded at around $43.13 with a P/E ratio of 16.49 and P/S ratio of 3.21.
Added: Anadarko Petroleum Corp. (APC, Financial)
Carl Icahn added to his holdings in Anadarko Petroleum Corp. by 11.68%. His purchase prices were between $52.73 and $70.47, with an estimated average price of $59.8. The impact to his portfolio due to this purchase was 1.82%. His holdings were 16,084,356 shares as of 09/30/2008.
Anadarko Petroleum Corporation is one of the world's largest independentoil and gas exploration and production companies. Majority of the company'stotal proved reserves are located in the U.S. primarily in the mid-continent (Kansas Oklahoma and Texas) area offshore in the Gulf of Mexico and in Alaska. Most of the company's production is domestic and the remainder is from Algeria. The company also owns and operates gas gathering systems in its U.S. core producing areas. Anadarko Petroleum Corp. has a market cap of $17.3 billion; its shares were traded at around $37.68 with a P/E ratio of 6.47 and P/S ratio of 1.19. The dividend yield of Anadarko Petroleum Corp. stocks is 0.99%.
Added: Amylin Pharmaceuticals Inc. (AMLN, Financial)
Carl Icahn added to his holdings in Amylin Pharmaceuticals Inc. by 57.91%. His purchase prices were between $20.18 and $34.21, with an estimated average price of $25.8. The impact to his portfolio due to this purchase was 1.78%. His holdings were 10,718,586 shares as of 09/30/2008.
Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery development and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes SYMLIN injection and BYETTA injection. Amylin's research and development activities leverage the company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is located in San Diego California with over one thousand five hundred employees nationwide. Amylin Pharmaceuticals Inc. has a market cap of $950.93 million; its shares were traded at around $6.91 with P/S ratio of 1.11.
Added: The Williams Companies Inc. (WMB, Financial)
Carl Icahn added to his holdings in The Williams Companies Inc. by 84.32%. His purchase prices were between $25.49 and $37.66, with an estimated average price of $30.5. The impact to his portfolio due to this purchase was 1.75%. His holdings were 7,223,264 shares as of 09/30/2008.
Williams Companies moves manages and markets a variety of energy products including natural gas liquid hydrocarbons petroleum and electricity. Based in Tulsa Oklahoma Williams' operations span the energy value chain from wellhead to burner tip. The Williams Companies Inc. has a market cap of $9.65 billion; its shares were traded at around $16.69 with a P/E ratio of 6.51 and P/S ratio of 0.76. The dividend yield of The Williams Companies Inc. stocks is 2.26%.
Added: Quest Resource Corp. (QRCP, Financial)
Carl Icahn added to his holdings in Quest Resource Corp. by 41.47%. His purchase prices were between $2.6 and $10.26, with an estimated average price of $6.8. The impact to his portfolio due to this purchase was 0.02%. His holdings were 1,228,002 shares as of 09/30/2008.
Quest Resource Corp. has a market cap of $9.59 million; its shares were traded at around $0.4 with P/S ratio of 0.06.
New Purchase: Citigroup Inc. (C, Financial)
Carl Icahn initiated holdings in Citigroup Inc.. His purchase prices were between $15.72 and $20.39, with an estimated average price of $18.4. The impact to his portfolio due to this purchase was 0.37%. His holdings were 800,000 shares as of 09/30/2008.
Citigroup Inc. the leading global financial services company has some two hundred million customer accounts and does business in more than hundred countries providing consumers corporations governments and institutions with a broad range of financial products and services including consumer banking and credit corporate and investment banking securities brokerage and wealth management. Major brand names under Citigroup's trademark red umbrella include Citibank CitiFinancial Primerica Smith Barney and Banamex. Citigroup Inc. has a market cap of $48.45 billion; its shares were traded at around $8.89 with P/S ratio of 1.77. The dividend yield of Citigroup Inc. stocks is 5.41%.
New Purchase: Endo Pharmaceuticals Holdings Inc. (ENDP, Financial)
Carl Icahn initiated holdings in Endo Pharmaceuticals Holdings Inc.. His purchase prices were between $20.58 and $25.19, with an estimated average price of $23.1. The impact to his portfolio due to this purchase was 0.36%. His holdings were 800,000 shares as of 09/30/2008.
Endo Pharmaceuticals Holdings Inc. through its wholly owned subsidiaries Endo Pharmaceuticals Inc. and Endo Inc. is engaged in the research development sales and marketing of branded and generic prescription pharmaceuticals used primarily for the treatment and management of pain. Endo Pharmaceuticals Holdings Inc. has a market cap of $2.34 billion; its shares were traded at around $19.97 with a P/E ratio of 10.78 and P/S ratio of 1.92.
New Purchase: Advanced Micro Devices Inc. (AMD, Financial)
Carl Icahn initiated holdings in Advanced Micro Devices Inc.. His purchase prices were between $4.28 and $6.29, with an estimated average price of $5.3. The impact to his portfolio due to this purchase was 0.19%. His holdings were 1,600,000 shares as of 09/30/2008.
Advanced Micro Devices Inc. is a world-class company with the innovation execution and vision to grow our leadership position in the industry. Today's world-class companies share three essential characteristics. First they deliver innovative products and technologies that customers want. Second they have established a proven track record of fast efficient manufacturing execution. And third they have a bold vision of where to take their business and often their industry. Over the course of AMD?s three decades in business silicon and software have become the steel and plastic of the worldwide digital economy. Technology companies have become global pacesetters making technical advances at a prodigious rate always driving the industry to deliver more and more faster and faster. AMD?s dedication to customer-centric innovation and competitive spirit is an unbroken thread running from our early days in the integrated circuit business through an ever-broadening product por Advanced Micro Devices Inc. has a market cap of $1.52 billion; its shares were traded at around $2.5 with P/S ratio of 0.23.
New Purchase: Exelixis Inc. (EXEL, Financial)
Carl Icahn initiated holdings in Exelixis Inc.. His purchase prices were between $4.8 and $7.12, with an estimated average price of $6.1. The impact to his portfolio due to this purchase was 0.18%. His holdings were 1,307,280 shares as of 09/30/2008.
Exelixis Inc. is a leader in the fields of model system genetics andcomparative genomics. These fields involve the systematic study of simpleorganisms such as fruit flies nematodes mice zebrafish and simple plants to rapidly and efficiently determine gene function and establish its commercial utility in humans and other commercially important biological systems. The proprietary technologies provide a rapid efficient and cost-effective way to move beyond DNA sequence data to understand the function of genes and the proteins that they encode. Exelixis Inc. has a market cap of $316.80 million; its shares were traded at around $3 with P/S ratio of 2.70.
New Purchase: TakeTwo Interactive Software Inc. (TTWO, Financial)
Carl Icahn initiated holdings in TakeTwo Interactive Software Inc.. His purchase prices were between $16.16 and $25.07, with an estimated average price of $22.9. The impact to his portfolio due to this purchase was 0.17%. His holdings were 461,128 shares as of 09/30/2008.
Take-Two Interactive Software Inc. is a leading worldwide developer publisher and distributor of interactive software games. The company's software operates on multimedia personal computers and video game console platforms. They are one of the largest distributors of interactive software games in the United States and one of the top publishers of interactive software games in Europe. TakeTwo Interactive Software Inc. has a market cap of $798.35 million; its shares were traded at around $10.29 with a P/E ratio of 7.33 and P/S ratio of 0.53.
Reduced: Time Warner Cable Inc. (TWC, Financial)
Carl Icahn reduced to his holdings in Time Warner Cable Inc. by 32.25%. His sale prices were between $25.24 and $28.85, with an estimated average price of $26.9. The impact to his portfolio due to this sale was -0.22%. Carl Icahn still held 1,248,474 shares as of 09/30/2008.
Time Warner Cable Inc. is the second-largest cable operator in the U.S. and an industry leader in developing and launching innovative video data and voice services. They deliver their services to customers over technologically-advanced well-clustered cable systems that pass approximately 26 million homes. Time Warner Cable Inc. has a market cap of $18.92 billion; its shares were traded at around $19.37 with a P/E ratio of 16.51 and P/S ratio of 1.12.
Sold Out: Applera Corp. Applied Biosystems Group (ABI)
Carl Icahn sold out his holdings in Applera Corp. Applied Biosystems Group. His sale prices were between $32.99 and $36.56, with an estimated average price of $35.4. The impact to his portfolio due to this sale was less than 0.01%.
APPLIED BIOSYSTEMS INC. (formerly known as Applera Corporation) is a global leader in the development and marketing of instrument-based systems consumables software and services for academic research the life science industry and commercial markets. Driven by its employees' belief in the power of science to improve the human condition the company commercializes innovative technology solutions for DNA RNA protein and small molecule analysis. Customers across the disciplines of academic and clinical research pharmaceutical research and manufacturing forensic DNA analysis and agricultural biotechnology use the company?s tools and services to accelerate scientific discovery improve processes related to drug discovery and development detect potentially pathogenic microorganisms and identify individuals based on DNA sources. Applied Biosystems has a comprehensive service and field applications support team for a global installed base of high-performance genetic and prote Applera Corp. Applied Biosystems Group has a market cap of $4.95 billion; its shares were traded at around $29.05 with a P/E ratio of 15.27 and P/S ratio of 2.19. The dividend yield of Applera Corp. Applied Biosystems Group stocks is 0.56%.
